HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Kao Q1

This article was originally published in The Rose Sheet

Executive Summary

Consumer product sales in North America and Europe grew 6% to $233.4 mil. (¥1=$.009) largely on sales of John Frieda Brilliant Brunette launch, Japanese firm states in first quarter (ended June 30) sales and earnings release July 22. Brilliant Brunette launched in January (1"The Rose Sheet" Jan. 5, 2004, p. 4). Worldwide consumer products sales were up 6% to $1.5 bil. Excluding negative currency translation due to depreciation of the yen, consumer sales would have been up 7.2%, firm notes. Net sales advanced 6.5% to $2.06 bil., while net income increased 12.6% to $155 mil. Kao recently announced the appointment of Motoki Ozaki to post of president and CEO, replacing former head Takuya Goto...

You may also be interested in...

John Frieda Targets Brilliant Brunettes With New Hair Care Range

John Frieda is supporting the debut of its Brilliant Brunette hair care collection with print and television ads breaking this spring, the Kao division said

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts